Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.